October 20, 2017 9:35 AM ET

Biotechnology

Company Overview of 3-V Biosciences, Inc.

Key Executives for 3-V Biosciences, Inc.

NameBoard RelationshipsTitleAge
Merdad V. Parsey M.D., Ph.D.12 RelationshipsChief Executive Officer, President and Director--
Urs Greber Ph.D.No RelationshipsCo-Founder--
David M. Mott 206 RelationshipsExecutive Chairman51
Lucas Pelkmans Ph.D.No RelationshipsCo-Founder--
Rekha Hemrajani No RelationshipsChief Financial Officer and Senior Vice President of Business & Financial Operations--
View More Key Executives

3-V Biosciences, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
David M. Mott 206 RelationshipsMersana Therapeutics, Inc.51
Merdad V. Parsey M.D., Ph.D. 12 Relationships3-V Biosciences, Inc.--
Ed Harlow Jr., Ph.D. 12 Relationships3-V Biosciences, Inc.--
Robert J. Garland M.D. 46 RelationshipsNew Enterprise Associates--
Joseph D. Puglisi Ph.D. 22 RelationshipsPTC Therapeutics, Inc.--
View All Board Members

3-V Biosciences, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Jr., Ph.D.Ed Harlow12 Relationships6 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
388.0K
Bonus
242.2K
Total Short Term Compensation
483.6K
Total Value of Options
17.8M
Compensation as of Fiscal Year
3-V Biosciences, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Verseon Corporation Appoints Robert W. Karr as Non-Executive Class II Director
October 20, 2017 6:00 AM ET
Neurocrine Biosciences, Inc. Announces Management Changes
October 19, 2017 9:26 PM ET
AveXis, Inc. Announces Management Changes
October 19, 2017 8:58 PM ET
Peregrine Pharmaceuticals, Inc. and Avid Bioservices, Inc. Appoint Mark R. Bamforth as an Independent Member of the Board of Directors
October 19, 2017 12:05 PM ET
Cellect Biotechnology Ltd. Announces Executive Changes
October 19, 2017 11:05 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact 3-V Biosciences, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.